WDA
BMY icon

Wendell David Associates’s Bristol-Myers Squibb BMY Stock Holding History

Wendell David Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$725K Sell
12,578
-454
-3% -$26.1K 0.08% 106
2026
Q1 		$790K Sell
13,032
-399
-3% -$23.3K 0.09% 98
2025
Q4 		$724K Sell
13,431
-600
-4% -$28.9K 0.07% 102
2025
Q3 		$633K Sell
14,031
-4,600
-25% -$215K 0.06% 110
2025
Q2 		$862K Sell
18,631
-1,013
-5% -$49.7K 0.09% 97
2025
Q1 		$1.2M Sell
19,644
-557
-3% -$32.5K 0.12% 86
2024
Q4 		$1.14M Buy
20,201
+992
+5% +$55.4K 0.11% 87
2024
Q3 		$994K Sell
19,209
-515
-3% -$24.2K 0.1% 91
2024
Q2 		$819K Hold
19,724
– – 0.08% 94
2024
Q1 		$1.07M Sell
19,724
-228
-1% -$11.6K 0.11% 85
2023
Q4 		$1.02M Buy
19,952
+853
+4% +$44.8K 0.11% 86
2023
Q3 		$1.11M Buy
19,099
+800
+4% +$49K 0.13% 81
2023
Q2 		$1.17M Hold
18,299
– – 0.13% 80
2023
Q1 		$1.27M Hold
18,299
– – 0.15% 80
2022
Q4 		$1.32M Hold
18,299
– – 0.16% 79
2022
Q3 		$1.3M Hold
18,299
– – 0.18% 79
2022
Q2 		$1.41M Hold
18,299
– – 0.18% 79
2022
Q1 		$1.34M Hold
18,299
– – 0.15% 81
2021
Q4 		$1.14M Hold
18,299
– – 0.12% 84
2021
Q3 		$1.08M Hold
18,299
– – 0.12% 84
2021
Q2 		$1.22M Sell
18,299
-795
-4% -$51.8K 0.14% 83
2021
Q1 		$1.21M Sell
19,094
-339
-2% -$21.1K 0.15% 82
2020
Q4 		$1.21M Buy
19,433
+172
+0.9% +$10.6K 0.15% 82
2020
Q3 		$1.16M Sell
19,261
-50
-0.3% -$3.01K 0.15% 81
2020
Q2 		$1.14M Sell
19,311
-150
-0.8% -$8.97K 0.16% 80
2020
Q1 		$1.08M Sell
19,461
-750
-4% -$45.8K 0.18% 80
2019
Q4 		$1.3M Buy
20,211
+5,775
+40% +$331K 0.18% 83
2019
Q3 		$732K Sell
14,436
-100
-0.7% -$4.7K 0.11% 100
2019
Q2 		$659K Sell
14,536
-500
-3% -$23.3K 0.1% 102
2019
Q1 		$717K Sell
15,036
-200
-1% -$9.96K 0.11% 100
2018
Q4 		$792K Sell
15,236
-1,749
-10% -$94K 0.14% 94
2018
Q3 		$1.05M Hold
16,985
– – 0.16% 91
2018
Q2 		$940K Sell
16,985
-651
-4% -$35.2K 0.16% 94
2018
Q1 		$1.11M Sell
17,636
-100
-0.6% -$6.43K 0.2% 91
2017
Q4 		$1.09M Buy
17,736
+1,550
+10% +$96.9K 0.19% 93
2017
Q3 		$1.03M Buy
16,186
+575
+4% +$33.6K 0.18% 93
2017
Q2 		$870K Buy
15,611
+43
+0.3% +$2.34K 0.16% 97
2017
Q1 		$847K Hold
15,568
– – 0.16% 95
2016
Q4 		$910K Sell
15,568
-708
-4% -$38.7K 0.18% 96
2016
Q3 		$878K Hold
16,276
– – 0.17% 97
2016
Q2 		$1.2M Sell
16,276
-1,333
-8% -$94.2K 0.24% 89
2016
Q1 		$1.13M Buy
17,609
+2,000
+13% +$126K 0.22% 89
2015
Q4 		$1.08M Buy
15,609
+1,250
+9% +$82.6K 0.21% 89
2015
Q3 		$847K Hold
14,359
– – 0.17% 96
2015
Q2 		$948K Buy
+14,359
New +$946K 0.18% 94

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Wendell David Associates's BMY Position: Q2 2026 in Review

Wendell David Associates reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2026, selling an estimated $26.1K and leaving 12,578 shares worth $725K. The position accounts for 0.08% of the portfolio, ranked #106.

Wendell David Associates first reported a position in BMY in Q2 2015 and has held it in 45 quarters since. The position peaked at $1.41M in Q2 2022. 964 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Wendell David Associates held 12,578 shares of Bristol-Myers Squibb worth $725K as of Q2 2026.
  • Wendell David Associates sold 454 Bristol-Myers Squibb shares in Q2 2026, an estimated $26.1K.
  • Bristol-Myers Squibb made up 0.08% of Wendell David Associates's portfolio in Q2 2026, its #106 holding.
  • Wendell David Associates first reported a position in Bristol-Myers Squibb in Q2 2015 and has held it in 45 quarters since.
  • Wendell David Associates's Bristol-Myers Squibb position peaked at $1.41M in Q2 2022.
  • 964 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Wendell David Associates's 13F filing for Q2 2026, filed 27 Jul 2026.